Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation – Labiotech.eu (blog)
Labiotech.eu (blog) |
Shire's Hemophilia Gene Therapy Boosted by Orphan Drug Designation
Labiotech.eu (blog) The FDA has granted orphan drug designation to Shire's hemophilia A gene therapy, giving it the boost it needs to catch up with others in the field. Shire specializes in the development of drugs for rare diseases, including hemophilia A – a bleeding … FDA Orphan Drug Designation Granted to Hemophilia Gene Therapy; Clinical Studies to Begin Soon Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of … |
